The Compelling Part of Vical (VICL) Isn’t a Swine Flu Vaccine - Transworld News
Biotech company Vical Inc. (VICL) posted encouraging news yesterday regarding the development of its swine flu treatment, sending shares higher by more than 20%. However, today’s pullback offers a sobering perspective on just how competitive the
US company makes first batch of swine flu vaccine - Terra Daily
A US company that on Tuesday was awarded a 35-million-dollar contract to develop an influenza vaccine using insect cell technology has produced a first batch against (A)H1N1 flu, company boss Dan Adams said. “We turned out our first batch of doses
Novavax in multimillion Spanish deal - Courier-Post
TRENTON — Vaccine developer Novavax Inc. has signed a deal with Spain’s health ministry and a specialty drugmaker there to license its genetically engineered technology to produce pandemic and seasonal flu vaccines and build that country’s first